well-posit challeng lab
landscap miss rais concern
increment color updat lt guid
heel last night cut guid link held analyst day ny
learn cut larg due higher patient concess lower
cash collect conserv reserv calcul ca fire weather
natur event smaller part new ep guid meant
worst case scenario result could come better expect cash
collect improv year-end still tri find root caus miss
put conserv view revenu accrual new long term guid
total sale ep cagr includ contribut
vs prior organ growth in-lin prior estim
dislik messi lab like long-term driver
overal happi lack visibl miss rais
execut concern overhang stock howev potenti volum gain
recent open exclus lab contract signific outlin
lab primer think labcorp lh win share fragment lab
industri consolid face mount reimburs pressur catalyz
pama protect access medicar act moreov posit dgx
aggress push consumer healthcar well potenti
monet patient data point collect past year via
relationship contract research organ reiter buy
rate cut estim lower end growth guid rang leav room
upsid give full credit out-year cut po
base new ep estim in-lin
compani averag two year forward multipl last five year
lower estim po
forecast revenu adj ep
see revenu adj ep
pleas see page detail
full definit iqmethod sm measur see page
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
net dbt
return capit employ
return equiti
iqmethod sm qualiti earn
net incom cont oper
chang work capit
full definit iqmethod sm measur see page
largest provid clinic diagnost
test relat servic deliv
nation network full-servic clinic
laboratori patient servic center
clinic lab oper highli competit
price-deflationari environ howev
see upsid potenti elev lab
consolid catalyz medicar
opportun monet lab data
although trend may slow materi
believ quest scale customer-fac
mindset help compani leverag core lab
busi drive share gain margin
new access health system provid share gain opportun
character new open health system opportun market mostli
sit hospit lab compani could potenti reach share
current look add insur live
access insur live highest decad reach
live due new win includ unitedhealthcar
cross shield georgia horizon outsiz opportun
start identifi highest-volum account repres
unh lab busi current lh add
account quest loyalist mean like send busi quest
exclus assum loyalist send test would translat
potenti addit revenu alon build
ground work contract chang sinc announc may howev
come execut remain see ultim trade-off
volum gain price concess relat move in-network
strong cash flow flexibl balanc sheet allow contribut
despit higher patient concess issu still strong cash gener
busi gener capital-expenditure need therefor
compani flexibl lever remain invest grade
current current cash deploy plan dri power
therefor allow compani previou annual contribut
target oper cash flow
pama wors catalyz consolid
expect see ebitda headwind due pama
hit compani
predict similar data collect method appli pama
modest impact vs recal nation lab
medicar exposur roughli hospit outreach lab typic
greater scale better opm profil manag hope pama
catalyz hospit lab deal potenti profession lab servic pl agreement
target cost save annual translat
year although histor find number hard measur
new save initi address reduc denial opportun
patient concess improv digit
save five year standard autom five
year optim denial issu specif industry-wid
problem net denial rate third-parti payer work
undisclos larg health plan target reach zero denial rate commun
payment option prior test adopt real-tim adjud tool
continu expand retail presenc
continu open psc retail pharmaci groceri store help
expand compani consum reach access patient current one-third
quest patient servic center psc retail set around retail
partner store compani target get percentag partner store
next year
data monetar horizon
patient data point collect past ten year shape
monetar potenti elig patient demograph inform contract
research organ bound partnership
intrigu idea given on-going data push think could
signific revenu stream point
reimburs pressur peak moder beyond
previous commun earn expect reimburs
pressur includ around pama year
around relat new health plan in-network deal around
factor beyond compani expect pressur moder health
plan price concess annual pama impact start moder
addit advanc diagnost becom increasingli crow space lab
industri may experi price pressur tradit higher margin
esoter test arena well
increas uncertainti timelin hard predict
compani growth heavili reli acquisit unpredict deal
time becom issu recent base channel check lab strategi
forefront major hospit execut mind therefor may
take longer nation lab close outreach acquisitions/profession lab servic
deal inde among hospit us outreach lab work today
largest hospit system among top institut may
consid insourc accumul scale instead sell lab practic
flag vast major hospit gener
revenu would much easier struck deal
price object base price-to-earnings multipl line compani
averag two-year forward multipl last two year see upsid
potenti elev lab consolid catalyz medicar reimburs cut
pama retail clinic opportun monet lab data believ quest
scale customer-fac mindset help compani leverag core lab busi
drive share gain margin expans
upsid risk faster expect materi hospit lab consolid
trend margin expans due higher specialti test mix faster volum growth
consum genom trend
downsid risk greater expect price headwind lower expect test
volum growth competit execut risk integr risk data privaci risk
derik de bruin herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
qualiti earn
iqmethod smi set bofa merril lynch standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa merril lynch
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
